* above transactions were completed by Ceros Capital Markets or by Chris Dewey prior to joining Ceros Capital Markets.view portfolio
Ceros Capital Markets is a global investing platform for companies in the medical device, robotics, and digital health space. We bring institutional quality deals to sophisticated investors who understand the synergies between innovation and healthcare.
Our deals have been sourced and vetted by the Ceros team and our strategic advisors, who are among the most successful serial entrepreneurs in MedTech. These deals provide investors with the opportunity to join us in pushing the boundaries of robotics, disrupting the medical industry, and fueling innovation to help change lives.Learn More
Momentis Annovo®May 18, 2021
Momentis is a medical device company that develops robotic surgical solutions that features miniature humanoid-shaped robotic arms. Ceros Capital Markets acted as a placement agent for +$40M in Momenti's Series D financing. Read More
Ceros Financial Services announced that Ceros Capital Markets, its investment banking division, has completed an approximately $15 million Series A round for GT Metabolic Solutions, which has developed minimally-invasive incisionless bypass technology for bariatric, metabolic and digestive surgeryRead More
Patient procedures performed at HCA Florida Kendall Hospital and The Women's Hospital at Jackson Memorial with first and only FDA-authorized surgical robot with humanoid-shaped armsRead More
If you’re interested in investing on the Ceros Capital Markets platform or pitching your company, please fill out the request form below with the appropriate selection.